Herceptin (Genentech, Inc.)
Welcome to the PulseAid listing for the Herceptin drug offered from Genentech, Inc.. This HER2 Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | Trastuzumab |
| SUBSTANCE NAME: | TRASTUZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HER2 Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-02-10 |
| END MARKETING DATE: | 0000-00-00 |
Herceptin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Herceptin from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/7.4mL) |
| START MARKETING DATE: | 2017-02-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-132_26820703-edfa-4f8a-be67-f8cb08fd681b |
| PRODUCT NDC: | 50242-132 |
| APPLICATION NUMBER: | BLA103792 |
Other TRASTUZUMAB Pharmaceutical Manufacturers / Labelers:
